NP / PA
Gregory, Marilyn
Gregory, Marilyn was paid $1.21M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is 76817, Ultrasound, pregnant uterus, real time with image documentation, transvaginal — 16% of everything it billed.
33Billing provider infoGREGORY, MARILYN
CONROE, TX 77301
CONROE, TX 77301
33aNPI1861564072assigned 11/14/2006
33bProvider typeWomen's Health Nurse Practitioner
28Total paid$1.21M
24GClaims53,689
24DCodes billed54
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Women's Health Nurse Practitioner providers in Texas
Rank by total paid#3 of 21
Median peer was paid$73K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 229 | $11K | |
| 2019 | 726 | $26K | |
| 2020 | 3,491 | $91K | |
| 2021 | 7,973 | $183K | |
| 2022 | 12,838 | $345K | |
| 2023 | 14,329 | $306K | |
| 2024incomplete | 14,103 | $247K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 16% | 3,220 | 2,515 | $194K |
| 76830 | Ultrasound, transvaginal | 15% | 1,989 | 1,901 | $178K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 9.2% | 808 | 776 | $111K |
| 87800 | 7.1% | 2,387 | 2,334 | $85K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.6% | 2,864 | 2,766 | $80K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.6% | 2,864 | 2,766 | $80K |
| 87806 | 2.9% | 1,475 | 1,419 | $35K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.7% | 594 | 581 | $33K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.4% | 737 | 653 | $29K |
| 86703 | 2.2% | 2,312 | 2,280 | $27K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 2.1% | 412 | 353 | $26K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2.0% | 291 | 285 | $25K |
42 more codes
| 99000 | 2.0% | 2,247 | $24K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 1,692 | $23K |
| 86762 | 1.8% | 1,859 | $22K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 3,365 | $21K |
| 81025 | 1.5% | 2,562 | $18K | |
| 80061 | Lipid panel | 1.5% | 2,503 | $18K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.4% | 2,091 | $17K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.1% | 262 | $14K |
| 86787 | 1.1% | 1,372 | $13K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.1% | 233 | $13K |
| 84144 | 1.0% | 767 | $12K | |
| H1010 | Non-medical family planning education, per session | <1% | 1,013 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 823 | $11K |
| 86592 | <1% | 2,909 | $10K | |
| 84702 | <1% | 777 | $10K | |
| 82947 | <1% | 2,732 | $8K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 110 | $8K |
| 76813 | <1% | 80 | $7K | |
| 81003 | <1% | 3,334 | $6K | |
| 86580 | <1% | 754 | $6K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 356 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 385 | $5K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 71 | $4K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 42 | $4K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 34 | $3K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 324 | $3K |
| 83655 | <1% | 256 | $3K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 13 | $1K |
| 82950 | <1% | 235 | $877.80 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 20 | $777.84 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 52 | $722.80 |
| 87481 | <1% | 94 | $678.04 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 16 | $662.08 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 47 | $432.68 |
| 90715 | <1% | 13 | $415.42 | |
| 90461 | <1% | 52 | $390.23 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 40 | $364.80 |
| 87420 | <1% | 26 | $303.68 | |
| 86696 | <1% | 12 | $267.60 | |
| 90658 | <1% | 120 | $0.48 | |
| 90680 | 0% | 12 | $0.00 | |
| 90670 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.